deferoxamine has been researched along with Spherocytosis, Hereditary in 2 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Spherocytosis, Hereditary: A group of familial congenital hemolytic anemias characterized by numerous abnormally shaped erythrocytes which are generally spheroidal. The erythrocytes have increased osmotic fragility and are abnormally permeable to sodium ions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Franchini, M | 1 |
| Gandini, G | 1 |
| Girelli, D | 1 |
| Lippi, G | 1 |
| de Gironcoli, M | 1 |
| Aprili, G | 1 |
| Reddemann, H | 1 |
2 other studies available for deferoxamine and Spherocytosis, Hereditary
| Article | Year |
|---|---|
Association of phlebotomy and subcutaneous bolus injection of deferoxamine for the treatment of anemic patients with iron overload.
Topics: Anemia; beta-Thalassemia; Combined Modality Therapy; Deferoxamine; Female; Humans; Injections, Subcu | 2001 |
[Exchange transfusion and splenectomy for hyperbilirubinemia caused by hereditary spherocytosis in the neonatal period].
Topics: Deferoxamine; Exchange Transfusion, Whole Blood; Female; Hemosiderosis; Humans; Hyperbilirubinemia, | 1967 |